SAGE Therapeutics Announces Second Quarter 2015 Financial Results and Highlights Recent Progress

Go back to SAGE Therapeutics Announces Second Quarter 2015 Financial Results and Highlights Recent Progress

SAGE Therapeutics (SAGE) Misses Q2 EPS by 22c

August 12, 2015 6:32 AM EDT

SAGE Therapeutics (NASDAQ: SAGE) reported Q2 EPS of ($0.90), $0.22 worse than the analyst estimate of ($0.68).

For earnings history and earnings-related data on SAGE Therapeutics (SAGE) click here.

... More